... with Merck & Co. for the use of TLR agonists as vaccine adjuvants for cancer, infectious diseases and Alzheimer's disease. For more information, visit http://www.iderapharma.com . This press release contains forward-looking statements concerning ...
http://www.businesswire.com/news/topix/20130401005284/en
http://www.businesswire.com/news/topix/20130401005284/en
No comments:
Post a Comment